Douglas A. Treco serves as Executive at Ra Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Douglas A. Treco has executed 7 insider transactions totaling $1.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 6, 2025 involved purchasing 20,000 shares valued at $1.1M.
Douglas A. Treco currently holds 22,000 shares of Ra Pharmaceuticals, Inc. (RARX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas A. Treco has been a net buyer of RARX stock. They have purchased $1.1M and sold $52.2K worth of shares.
Douglas A. Treco's most recent insider trade was on Aug 6, 2025, when they purchased 20,000 shares at $57.03 per share.
Get notified when new Form 4 filings are submitted
| $4.00 |
| Discretionary |
| Apr 2, 2024 | INZY | $52.2K | Sale | 7,523 | $6.94 | Discretionary |
| Apr 1, 2024 | INZY | $0 | Option Exercise | 25,000 | $N/A | Discretionary |
| Apr 2, 2020 | RARX | $11.3M | Disposition | 234,707 | $48.00 | Discretionary |
| Feb 1, 2019 | RARX | $132.9K | Payment | 6,327 | $21.00 | Discretionary |
| Feb 1, 2019 | RARX | $0 | Option Exercise | 20,834 | $N/A | Discretionary |